New York Community Bancorp says FDIC will sell shares held by Signature Bank's replacement bank
Flagstar Bank parent New York Community Bancorp Inc. (NYCB) on Tuesday said that the FDIC had agreed to sell 39 million company shares currently owned by the institution that the agency set up in place of the recently-failed Signature Bank. That financial institution, Signature Bridge Bank N.A., which the FDIC created in March to handle the failed bank's operations, will get all the proceeds from the offering. The offering comes after Flagstar, a regional bank, scooped up billions of the Signature successor bank's deposits, loans and cash from from the FDIC in March. Before the proposed offering, Signature Bridge Bank owned the 39 million shares via an "Equity Appreciation Instrument" -- issued to it by New York Community Bancorp as part of the asset purchase in March -- initially intended to allow the FDIC to participate in NYCB stock gains. Under the terms of that instrument, Signature Bridge Bank "agreed to use all reasonable efforts to sell the shares it owns by no later than June 8, 2023 and the Company agreed to use reasonable efforts to facilitate such a sale." Flagstar Bank runs 435 bank branches in the Northeast and Midwest, as well as in the Southeast and the West Coast. Shares of New York Community Bancorp rose 1.9% after hours.
-Bill Peters
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-16-23 1806ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth